Treatment of RCC CSCs overexpressing notch1 with CXCR4 inhibitor AMD3100 (5 μM, 24 h) could suppress its invasive and migratory capability (Fig. 6c–f). The gene discussed is NOTCH1; the disease is renal cell carcinoma.